"Tennessee families with seriously ill children are

New Post Public Reply Private Reply Replies (1) Message Board
bellsandwhistles
"Tennessee families with seriously ill children are fleeing the state for Colorado"

(When Big Pharma owns a state. Senator Lamarr Alexander from Tennessee, high ranking and powerful, was the fourth highest recipient of Big Pharma campaign "contributions" in 2013-2014. Tennesseans take second billing as the most over-medicated people in the US. More prescriptions per capita are written in Tennessee than in 48 states. According to Pro Publica's "Dollars for Docs," Big Pharma owns influential Tennessean medical professionals, paying them millions of dollars to salute and advocate the newest Big Pharma drugs to their fellow professionals and professional associations. In 2009, key Tennessee doctors received about $8mil for Big Pharma advocacy. In 2012 , doctors nationwide received $2 billion in direct payments and gratuities from 15 big drugmakers.)

Medical Marijuana And The Need To Leave Tennessee

by Abby White
Jan 23, 2014

Tennessee families with seriously ill children are fleeing the state for Colorado, where they'll have access to medical marijuana. The Mattison family left Nashville last week, and are settling into Colorado Springs with their three children, Neal (10), Sam (7) and Millie (22 months). Millie has been suffering infantile spasms since she was three months old and is already taking an adult dosage of her current medication. When her doctors wanted to increase the dosage further — with little hope for improvement — the Mattisons started researching medical marijuana.

Why?

Part of the answer, from today's Scene piece:

Millie sees a neurologist at the Neurometabolic Clinic at the Cincinnati Children's Hospital every three months. Between visits to Cincinnati, Millie frequents the emergency room at Vanderbilt. But the cause of her seizures is still unknown.

She's endured intubations, blood transfusions, spinal taps, MRIs, CAT scans, genetic testing and stints in the pediatric intensive care unit, one due to kidney shutdown from an anti-seizure ketogenic diet. She's been on as many as 11 medications at one time and relies upon a feeding tube. Her current medication, Sabril, leaves her lethargic and has severe potential side effects, including blindness.

"One study we looked at said that if two anti-epileptics don't work, there's a 10 percent chance that any of them will work," Penn says. "If four don't work, there's a 0.8 percent chance. We've been on six. Nothing has really helped that much. She sleeps 20, 22 hours a day — there's no way she can build any muscle tone or development skills.

Although HB 1385, also known as the Koozer-Kuhn Medical Cannabis Act, was presented by state Rep. Sherry Jones (D-Nashville) on 07 January, it stands little chance of passing. (courtesy of Big Pharma)

Paul Kuhn, whose wife Jeanne found relief in medical marijuana before she passed away from cancer in 1996, is the former national chairman of the lobbying group National Organization for the Reform of Marijuana Laws. Despite the current political climate and opposition to the bill, Kuhn, who continues to serve on NORML's board, is optimistic about HB 1385.

"It will pass," Kuhn states, with a confidence many sympathetic voters don't share. "We're very close to the tipping point. There will be, this year, probably five to eight additional states that pass. So do we want Tennessee to be holding up the rear? It doesn't do our state image any good to be the laggers in a very progressive movement."

On Monday, January 27, a symposium "Koozer-Kuhn: Re-establishing a Medical Cannabis Program in Tennessee" will be held at Vanderbilt Owen School of Management from 7-8:30 pm, featuring speeches from legislators and patients. This is an 80-seat hall and audio will be broadcast in adjacent rooms to handle overflow.


Big Pharma

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PureHealth Research Spotlights Simpler Supplement Trends

Updated Category News Views 0

What's Steering the Supplement Ship? Well, if you're paying any attention to the supplement space, you might've noticed something curious: folks are ditching complicated concoctions for good old fashioned simplicity. PureHealth Research, out of Manassas, is throwing the limelight on this trend, where people are handing in their multi-ingredient cocktail for a single...

Continue Reading
Nocpix's Evolution: New Thermal Riflescope Unveiled

Updated Category News Views 1

Raising the Thermal Image Bar When Nocpix, known for cutting-edge electro-optical tech, teases a new thermal riflescope, it's time for hunters to perk up. This ain't just another gadget. We're talking about equipment that elevates precision and brings an edge to the field. Scheduled for hunters who mean business, this next-gen scope is destined to redefine what it means...

Continue Reading
Affleck Joins Aflac in Unlikely Yet Fitting Alliance

Updated Category News Views 1

A Partnership Born from a Punning Connection Look, in this world of insurance and Hollywood glitz, it's not every day you see Ben Affleck sharing the screen with a talking duck. But here we are. Aflac—the giant in supplemental health insurance—and Ben Affleck have cozied up for a series of ads under Affleck’s direction, breathing life into what started as nothing...

Continue Reading
Freeport-McMoRan Hit with Legal Probe: What's Next?

Updated Category News Views 4

Investigating the Movers and Shakers at Freeport When legal hawks like Kahn Swick & Foti, LLC sink their teeth into something, you can bet it's not just to nibble. These folks have jumped headfirst into probing Freeport-McMoRan Inc. (NYSE:FCX), ready to dismantle any smoke screens that might have been thrown up after the unfortunate Grasberg Block Cave mine incident. The...

Continue Reading
XCOTTON Shines at IFA 2026: The New Horizon of Commerce

Updated Category News Views 2

Shifting Gears at the Checkout Counter Let's face it, we've all been there: you click, you pay, and then you wait. But what happens next is where brands often drop the ball. Sure, e-commerce has been all about getting us to trust the 'buy' button. That's where folks like XCOTTON are stepping up to the plate, giving us something else to consider. They were loud and clear...

Continue Reading
Morpho Unveils Versatile UV Printer at IFA 2026

Updated Category News Views 0

IFA 2026: A New Frontier for Desktop Printing You've seen your fair share of printers over the years, but when a company like Morpho steps onto the scene with a gadget that echoes innovation, it makes you perk up those market-ears. We're talking the big unveil of their desktop UV printer at the IFA 2026 in Berlin. Morpho's contraption isn't just spewing out ink; it's...

Continue Reading
Penetron Strengthens Midwest, Central USA Support Team

Updated Category News Views 3

Expansion of Penetron's Engineering Support Eyes are on the Midwest and Central USA as Penetron makes a strategic move to bolster their technical support dream team. They've snagged Sean Allison, a heavyweight with more than three decades' worth of grit and know-how from the construction battlefield. Sean, now stationed in the heart of America's Dairyland—Green Bay,...

Continue Reading
Why Buyers Are Flocking to Whidbey Island Homes

Updated Category News Views 0

Something's got folks eyeing Whidbey Island like a gambler with a hot tip—and it ain't just the thrill of a vacation spot. Anyone with half a brain knows real estate moves in waves, and right now, Whidbey Island's caught some serious momentum. You can't ignore the pull of natural beauty, access to city life, and that laid-back vibe that seems to whisper "slow down and...

Continue Reading
Papa John's Faces Securities Class Action Over Missteps

Updated Category News Views 3

Papa John's Stock Takes a Nosedive Here's a hot potato for you—Papa John's International, Inc. (NASDAQ: PZZA) just got slapped with a securities class action. This ain't a pie you want a slice of, not after the dough they lost in a day's trading frenzy. On August 6, our friends at Papa John's sent their investors scrambling as their stock tumbled from $29.75 to a stark...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 1

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading

Top 5 Most Recently Viewed Articles

SandboxAQ Secures $300 Million to Propel AI Quantum Technology

Updated Category News Views 237

SandboxAQ Raises Over $300 Million in Funding SandboxAQ, a startup focused on integrating quantum technology with artificial intelligence, has recently successfully completed a funding round where it raised over $300 million. This substantial investment has led to a remarkable increase in the company’s valuation, surpassing $5.6 billion. Utilizing Funds for Growth The...

Continue Reading
InventHelp Introduces the Innovative Cuddle Coat Blanket

Updated Category News Views 135

Introducing the Cuddle Coat: A Revolutionary Blanket Design Imagine a chilly morning where you want to sip your coffee and enjoy breakfast while staying warm. An inventive mind has tackled this common concern with a new creation—the Cuddle Coat. This innovative blanket design isn’t just about warmth; it cleverly ensures that your arms and hands remain free, providing...

Continue Reading
Lantronix Inc's Recent Stock Movements and Financial Growth

Updated Category News Views 96

Notable Insider Sales at Lantronix Inc Recently, Bernhard Bruscha, a prominent shareholder at Lantronix Inc (NASDAQ: LTRX), sold 49,532 shares of common stock in a significant transaction. This involved a series of trades with prices varying from $4.44 to $4.50, totaling about $221,596. The transactions had a weighted average price of $4.4738. Bruscha's Stake and...

Continue Reading
Innovative Tool Launches to Address Pharmacy Access Challenges

Updated Category News Views 126

New Mapping Tool Unveiled to Combat Pharmacy Shortages The National Community Pharmacists Association (NCPA) has joined forces with the University of Southern California (USC) to unveil an innovative interactive mapping tool designed to identify pharmacy shortage areas across the nation. This new resource is especially significant as it becomes publicly available for the...

Continue Reading
Moomoo Partners with Mets for Exciting $20,000 Fan Giveaway

Updated Category News Views 289

Moomoo Teams Up with Mets for Major Fan Engagement As baseball enthusiasts gear up for an exciting season, Moomoo, an innovative global investment platform, is thrilled to announce an engaging initiative for New York Mets fans. With the Mets closing in on their remarkable 50th win of the 2025 MLB season, Moomoo has committed a generous $20,000 cash giveaway to celebrate...

Continue Reading